1116 Long-term ocular safety of hydroxychloroquine in patients with childhood-onset SLE (cSLE) followed into adulthood

Wei Chen, Joanne Bargman, Murray Urowitz, Amanda Steiman, Dafna Gladman, Jorge Sanchez-Guerrero, Zahi Touma, Deborah Levy, Linda Hiraki, Andrea Knight, Earl Silverman
2021 Abstracts   unpublished
symptoms could only be found in patients with an established diagnosis of SLE. In addition, a few rheumatologists were concerned about labeling Type 2 symptoms as 'SLE' since they attributed these symptoms to co-morbid conditions. Conversely, two providers noted that Type 2 symptoms could sometimes be part of Type 1 SLE activity. Conclusion The Type 1 & 2 SLE model was well accepted by both patients and rheumatologists and considered as a useful approach to identifying and treating SLE
more » ... tions. The concern that SLE could be mis-diagnosed in patients with only Type 2 symptoms indicates the importance of limiting the use of this model to patients meeting classification criteria for SLE. Many patients and several physicians suggested that the connection between Type 1 and 2 SLE may reflect an inflammation-driven subset of Type 2 symptoms.
doi:10.1136/lupus-2021-lupus21century.59 fatcat:ojmyyooerrgqvjjzzxah6porke